Skip to content
Contact
About PORTAL
Our Team
Our Work
Innovation Incentives and Competition
Regulation and Clinical Evidence
Price, Value, and Access
Search Our Library
A Systematic Review of the Food and Drug Administration’s ‘Exception From Informed Consent’ Pathway
HOME
/
Research Publications
/
A Systematic Review of the Food and Drug Administration’s ‘Exception From Informed Consent’ Pathway